Scott Syroka is a former Johnston city council member.
Does anyone remember voting for Rosalind Brewer? That’s the Walgreens CEO with the power to decide what kind of health care millions of Americans, including countless Iowans, get to access. The latest battle over reproductive rights shows us how.
Last Friday, the U.S. Supreme Court announced it was hitting pause on an early April decision by Trump-appointed federal judge Matthew J. Kacsmaryk to suspend approval of mifepristone previously granted by the Food and Drug Administration more than two decades ago.
If you’re not familiar yet, mifepristone is a safe and commonly used pill in abortion care. It can also be used to treat medical conditions like uterine fibroids (noncancerous growths in the uterus) as well as Cushing syndrome, a condition caused by prolonged exposure to high cortisol levels.
In the wake of the Supreme Court’s decision, pundits argued this meant that access to mifepristone would continue to be available to all Americans. Steve Vladeck, CNN Supreme Court analyst and professor at the University of Texas School of Law, went as far as to say, “…nothing is going to change with respect to mifepristone access until and unless the court both takes the case on the merits and sides with the challengers.”
But that statement is not true. Access to mifepristone was already restricted for millions of Americans prior to Judge Kacsmaryk’s decision, so the Supreme Court’s stay on his ruling only prolongs a status quo of continued restrictions for too many. Corporate monopolies like Walgreens are the reason why.Continue Reading...